Percutaneous Ventricular Assist Device | UHC Coverage Update

TL;DR: UnitedHealthcare modified its percutaneous ventricular assist device coverage policy, effective October 1, 2025. Here's what billing teams need to do.

UnitedHealthcare updated its Medicare Advantage medical policy for percutaneous ventricular assist devices, affecting CPT codes 33990, 33991, and 33995. The policy under code percutaneous-ventricular-assist-device sets strict medical necessity criteria for device insertion — and if your claims don't reflect those criteria precisely, denials follow fast. This is a high-stakes policy for cardiology and cardiac surgery billing teams, and the October 1, 2025 effective date is already here.

Quick-Reference Table

UnitedHealthcare Percutaneous Ventricular Assist Device Coverage Criteria and Medical Necessity Requirements 2025

The UHC percutaneous ventricular assist device coverage policy is one of the more restrictive device policies in Medicare Advantage. UnitedHealthcare covers percutaneous insertion of an endovascular cardiac assist device — billed under CPT 33990, 33991, or 33995 — only in three specific life-threatening situations.

Here are the three covered indications, pulled directly from the policy:

There's a fourth condition layered on top of all three: an intra-aortic balloon pump (IABP) must not be expected to be sufficient. If the clinical record doesn't document why IABP was inadequate or contraindicated, you're exposed to a medical necessity denial.

The policy also requires strict adherence to FDA approval guidelines. That's not a throwaway line. If the device was used off-label — or if the documentation doesn't explicitly tie the use to an FDA-approved indication — UHC has grounds to deny. Put that in your pre-submission checklist now.

On the prior authorization side: the policy doesn't explicitly list prior authorization requirements in the criteria section, but given the high-cost nature of these devices and the tight medical necessity criteria, assume PA is required and verify with UHC before the procedure wherever operationally possible. If you're billing for emergent placements where PA isn't feasible, document the emergent circumstances in full.

There is no CMS National Coverage Determination (NCD) for percutaneous ventricular assist devices. That means there's no federal floor to fall back on. Coverage is governed by Local Coverage Determinations (LCDs) and Local Coverage Articles (LCAs) where they exist — which varies by Medicare Administrative Contractor (MAC) jurisdiction. For states and territories without an applicable LCD or LCA, UHC's policy criteria above apply directly.

Check your MAC's local coverage determination before billing. If your region has an LCD for percutaneous ventricular assist devices, that LCD controls — not the UHC default criteria. Mixing these up is a fast path to a claim denial.

UnitedHealthcare Percutaneous Ventricular Assist Device Exclusions and Non-Covered Indications

The policy language is deliberate: the phrase "until the literature clearly demonstrates the efficacy of the treatment approach" precedes the entire coverage framework. That's not incidental wording. It signals that UHC views this technology as provisionally covered under limited conditions — not as a broadly established standard of care.

Any percutaneous ventricular assist device insertion that falls outside the three covered indications is not considered reasonable and necessary. That means elective hemodynamic support during high-risk PCI — a common real-world use of devices like the Impella — doesn't automatically qualify here. The clinical scenario has to map to cardiogenic shock, severe decompensated heart failure with threatening multi-organ failure, or intraoperative/postoperative circulatory complications.

If your cardiologists are using these devices for prophylactic support during complex coronary intervention without evidence of cardiogenic shock or multi-organ failure risk, those claims are vulnerable. Talk to your compliance officer and medical director before October 1, 2025 claims go out the door.

Coverage Indications at a Glance

UnitedHealthcare Percutaneous Ventricular Assist Device Billing Guidelines and Action Items 2025

The percutaneous ventricular assist device billing guidelines under this policy require tight coordination between your clinical documentation team and your coders. Here's what to do now.

CPT, HCPCS, and ICD-10 Codes for Percutaneous Ventricular Assist Device Under percutaneous-ventricular-assist-device

Covered CPT Codes (When Selection Criteria Are Met)

Key ICD-10-CM Diagnosis Codes

A Note on Code Selection Risk

The ICD-10 code list here includes both acute and chronic presentations of heart failure. Don't treat the presence of a code on this list as automatic coverage approval. UHC's medical necessity criteria require a life-threatening situation — that's a clinical standard, not just a code match. Unspecified codes like I50.9 (heart failure, unspecified) and I51.9 (heart disease, unspecified) are the weakest options on this list. Use them only when more specific coding genuinely isn't supported by the documentation. Unspecified codes paired with high-cost procedure codes invite scrutiny.